Labcorp (LH) Receives FDA De Novo Marketing Authorization for PGDx elio plasma focus Dx
Go back to Labcorp (LH) Receives FDA De Novo Marketing Authorization for PGDx elio plasma focus Dx| Laboratory Corp. of America Holding (NYSE: LH) | Delayed: 254.43 -1.39 (0.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $255.82 | 52 Week High | $141.32 | |||
| Open | $254.13 | 52 Week Low | $97.79 | |||
| Day High | $256.73 | P/E | 40.71 | |||
| Day Low | $253.05 | EPS | $6.25 | |||
| Volume | 763,241 | |||||
